ISOREA AB

ISOREA AB is a biotechnology and medical diagnostics company based in Solna, Sweden.

Founded in 2022, the company focuses on the early detection of Alzheimer’s disease and dementia. Its primary product is the AD Detect kit, a blood-test-based diagnostic tool designed to reliably identify early stages of dementia using two complementary ELISAs. Additionally, ISOREA has developed a food supplement aimed at supporting Alzheimer’s prevention through a unique combination of amino acids. The company aims to provide early dementia detection with its innovative diagnostic kits and aspires to become a leading player in the field of Alzheimer’s and dementia diagnostics. ISOREA plans to distribute its detection kits to hospitals, testing centers, and blood banks globally, with future plans for home test kits. The company collaborates with notable institutions like Karolinska Institutet and Davids Biotechnologie GmbH on research and development projects.